Patents/Inventors

Herriot Tabuteau

New York, NYUS94 patents

107 Patents

US126167522026
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US126167022026
Use of Reboxetine to Treat Narcolepsy
AXSOME THERAPEUTICS, Inc.
0 cites
US126114132026
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US125995762026
Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan
ANTECIP BIOVENTURES II LLC
0 cites
US125760782026
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US125694792026
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US125654782026
(s)-2-((s)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine
Axsome Therapeutics, Inc.
0 cites
US125645872026
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US125514892026
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US125514882026
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US125443832026
Methods of Treating Migraines with a Combination of a Meloxicam and a Rizatriptan
AXSOME THERAPEUTICS, Inc.
0 cites
US125443452026
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES LL LLC
0 cites
US124851762025
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US124786222025
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US124786782025
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US124722552025
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US124722562025
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US124722572025
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US124722582025
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US124721742025
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
Antecip Bioventures II LLC
0 cites
US124721562025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Antecip Bioventures II LLC
0 cites
US124721552025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Antecip Bioventures II LLC
0 cites
US124471382025
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US124471552025
Use of Reboxetine to Treat Narcolepsy
Axsome Therapeutics, Inc.
0 cites
US124338842025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US123904282025
Bupropion and Dextromethorphan for Reduction of Suicide Risk in Depression Patients
ANTECIP BIOVENTURES II LLC
0 cites
US123770912025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US123701962025
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US123701542025
Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan
ANTECIP BIOVENTURES II LLC
0 cites
US123646742025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US123576972025
Pharmaceutical Compositions Comprising Bupropion and Cysteine
AXSOME THERAPEUTICS, Inc.
0 cites
US123576402025
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US123109612025
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US122686932025
Pharmaceutical Compositions Comprising a Tolfenamic Acid
AXSOME THERAPEUTICS, Inc.
0 cites
US122631612025
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US122631452025
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US122460232025
Use of Reboxetine to Treat Narcolepsy
AXSOME THERAPEUTICS, Inc.
0 cites
US122396422025
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US121940062025
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US121940362025
Combination of Dextromethorphan and Bupropion for Treating Depression
ANTECIP BIOVENTURES II LLC
0 cites
US121940052025
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US121569142024
Pharmaceutical Compositions Comprising Bupropion and Cysteine
AXSOME THERAPEUTICS, Inc.
0 cites
US121468892024
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US121382602024
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US121280522024
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US121151652024
Use of Reboxetine to Treat Narcolepsy
Axsome Therapeutics, Inc.
0 cites
US121091782024
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US121026092024
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US121026062024
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
AXSOME THERAPEUTICS, Inc.
0 cites
US120901262024
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US120644112024
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US120424732024
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
Antecip Bioventures II LLC
0 cites
US120361942024
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US120361912024
Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan
ANTECIP BIOVENTURES II LLC
0 cites
US120051182024
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US120050362024
Methods of Administering Solriamfetol to Lactating Women
AXSOME MALTA Ltd.
0 cites
US119985522024
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US119864442024
Treatment of Poor Metabolizers of Dextromethorphan with a Combination of Bupropion and Dextromethorphan
Antecip Bioventures II LLC
0 cites
US119694212024
Bupropion as a Modulator of Drug Activity
Antecip Bioventures II LLC
0 cites
US119576862024
Compositions for Delivery of Reboxetine
Axsome Therapeutics, Inc.
0 cites
US119446832024
Pharmaceutical Compositions Comprising Meloxicam
Axsome Therapeutics, Inc.
0 cites
US119256362024
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
Antecip Bioventures II LLC
0 cites
US118965632024
Bupropion and Dextromethorphan for Reduction of Suicide Risk in Depression Patients
Antecip Bioventures II LLC
0 cites
US118833732024
Treatment of Depression in Certain Patient Populations
ANTECIP BIOVENTURES II LLC
0 cites
US118834082024
Reboxetine to Treat Narcolepsy
AXSOME THERAPEUTICS, Inc.
0 cites
US118722032024
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US118722042024
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US118651172024
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc
0 cites
US118447972023
Combination of Dextromethorphan and Bupropion for Treating Depression
ANTECIP BIOVENTURES II LLC
0 cites
US118396122023
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US118263702023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US118263542023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US118063542023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US118012502023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US117937762023
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US117864882023
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
AXSOME THERAPEUTICS, Inc.
0 cites
US117795542023
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US117795792023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US117716662023
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US117716672023
Methods of Administering Solriamfetol to Lactating Women
Axsome Malta Ltd.
0 cites
US117595222023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US117521442023
Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
ANTECIP BIOVENTURES II LLC
0 cites
US117380852023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US117307062023
Treatment of Depression in Certain Patient Populations
ANTECIP BIOVENTURES II LLC
0 cites
US117175182023
Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
ANTECIP BIOVENTURES II LLC
0 cites
US117124412023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116602742023
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
AXSOME THERAPEUTICS, Inc.
0 cites
US116602732023
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
0 cites
US116541522023
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
ANTECIP BIOVENTURES II LLC
0 cites
US116281492023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US116281732023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116177562023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116177912023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116177552023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116177472023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US116177282023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US116074562023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US116025632023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc.
0 cites
US115966272023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115901242023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115769092023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115768772023
Bupropion as Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115714282023
Pharmaceutical Compositions Comprising Meloxicam
AXSOME THERAPEUTICS, Inc
0 cites
US115714172023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115713992023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115410482023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites
US115410212023
Bupropion as a Modulator of Drug Activity
ANTECIP BIOVENTURES II LLC
0 cites